Maravai Historical Balance Sheet

MRVI Stock

USD 5.77 0.16 2.70%

Trend analysis of Maravai Lifesciences Holdings balance sheet accounts such as Total Current Liabilities of 89.4 M provides information on Maravai Lifesciences' total assets, liabilities, and equity, which is the actual value of Maravai Lifesciences to its prevalent stockholders. By breaking down trends over time using Maravai Lifesciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Maravai Lifesciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Maravai Lifesciences is a good buy for the upcoming year.

Maravai Lifesciences Inventory

38.12 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

About Maravai Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Maravai Lifesciences at a specified time, usually calculated after every quarter, six months, or one year. Maravai Lifesciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Maravai Lifesciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Maravai currently owns. An asset can also be divided into two categories, current and non-current.

Maravai Lifesciences Balance Sheet Chart

As of now, Maravai Lifesciences' Other Assets are increasing as compared to previous years. The Maravai Lifesciences' current Net Receivables is estimated to increase to about 74.3 M, while Total Assets are projected to decrease to under 1.5 B.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Retained Earnings

Add Fundamental

Total Assets

Total assets refers to the total amount of Maravai Lifesciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Maravai Lifesciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Maravai Lifesciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Maravai Lifesciences Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most accounts from Maravai Lifesciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Maravai Lifesciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	534.3M	585.3M	611.0M	559.4M
Total Assets	1.9B	2.3B	1.5B	1.5B

Short Long Term Debt Total Total Assets

Maravai Lifesciences balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets
Total Assets		0.9	0.97	0.88	0.87	0.94	0.87	0.58	0.25	-0.91	0.93	0.62	0.97	0.98	0.86	0.92	0.93	0.97	0.98	0.28	-0.93	0.93	0.95	0.61	0.94	0.99
Short Long Term Debt Total	0.9		0.83	0.95	0.72	0.94	0.74	0.79	0.48	-0.77	0.83	0.67	0.91	0.87	0.6	0.94	0.98	0.91	0.8	0.44	-0.98	0.69	0.86	0.83	0.94	0.92
Other Current Liab	0.97	0.83		0.8	0.93	0.91	0.84	0.56	0.1	-0.94	0.97	0.57	0.96	0.94	0.83	0.89	0.86	0.96	0.96	0.38	-0.87	0.91	0.88	0.55	0.89	0.97
Total Current Liabilities	0.88	0.95	0.8		0.59	0.86	0.63	0.6	0.66	-0.66	0.72	0.41	0.83	0.89	0.61	0.84	0.97	0.83	0.8	0.27	-0.96	0.67	0.9	0.67	0.86	0.86
Total Stockholder Equity	0.87	0.72	0.93	0.59		0.84	0.8	0.65	-0.19	-0.93	0.98	0.7	0.9	0.8	0.73	0.82	0.71	0.9	0.86	0.56	-0.72	0.83	0.69	0.59	0.8	0.89
Other Liab	0.94	0.94	0.91	0.86	0.84		0.88	0.73	0.26	-0.89	0.92	0.75	0.99	0.88	0.77	0.95	0.95	0.99	0.87	0.38	-0.94	0.82	0.85	0.69	0.99	0.96
Net Tangible Assets	0.87	0.74	0.84	0.63	0.8	0.88		0.47	-0.06	-0.95	0.83	0.79	0.9	0.81	0.87	0.89	0.79	0.9	0.86	0.11	-0.8	0.91	0.8	0.41	0.91	0.87
Property Plant And Equipment Net	0.58	0.79	0.56	0.6	0.65	0.73	0.47		0.18	-0.56	0.7	0.77	0.7	0.47	0.19	0.73	0.68	0.7	0.43	0.81	-0.69	0.32	0.39	0.95	0.71	0.66
Current Deferred Revenue	0.25	0.48	0.1	0.66	-0.19	0.26	-0.06	0.18		0.12	-0.01	-0.17	0.16	0.31	0.04	0.2	0.48	0.16	0.16	-0.1	-0.46	-0.01	0.41	0.34	0.27	0.21
Net Debt	-0.91	-0.77	-0.94	-0.66	-0.93	-0.89	-0.95	-0.56	0.12		-0.94	-0.74	-0.94	-0.85	-0.82	-0.92	-0.8	-0.94	-0.9	-0.35	0.81	-0.91	-0.79	-0.49	-0.9	-0.92
Retained Earnings	0.93	0.83	0.97	0.72	0.98	0.92	0.83	0.7	-0.01	-0.94		0.71	0.96	0.87	0.76	0.89	0.82	0.96	0.9	0.54	-0.83	0.85	0.78	0.66	0.88	0.96
Accounts Payable	0.62	0.67	0.57	0.41	0.7	0.75	0.79	0.77	-0.17	-0.74	0.71		0.75	0.5	0.5	0.75	0.62	0.75	0.54	0.41	-0.63	0.58	0.46	0.69	0.77	0.69
Cash	0.97	0.91	0.96	0.83	0.9	0.99	0.9	0.7	0.16	-0.94	0.96	0.75		0.91	0.81	0.95	0.93	1.0	0.92	0.4	-0.93	0.88	0.87	0.67	0.98	0.99
Non Current Assets Total	0.98	0.87	0.94	0.89	0.8	0.88	0.81	0.47	0.31	-0.85	0.87	0.5	0.91		0.86	0.87	0.91	0.91	0.98	0.2	-0.9	0.92	0.98	0.56	0.87	0.96
Non Currrent Assets Other	0.86	0.6	0.83	0.61	0.73	0.77	0.87	0.19	0.04	-0.82	0.76	0.5	0.81	0.86		0.69	0.69	0.81	0.92	-0.14	-0.68	0.96	0.87	0.21	0.77	0.83
Other Assets	0.92	0.94	0.89	0.84	0.82	0.95	0.89	0.73	0.2	-0.92	0.89	0.75	0.95	0.87	0.69		0.95	0.95	0.85	0.42	-0.96	0.8	0.84	0.7	0.96	0.94
Long Term Debt	0.93	0.98	0.86	0.97	0.71	0.95	0.79	0.68	0.48	-0.8	0.82	0.62	0.93	0.91	0.69	0.95		0.93	0.85	0.32	-1.0	0.76	0.91	0.71	0.96	0.93
Cash And Short Term Investments	0.97	0.91	0.96	0.83	0.9	0.99	0.9	0.7	0.16	-0.94	0.96	0.75	1.0	0.91	0.81	0.95	0.93		0.92	0.4	-0.93	0.88	0.87	0.67	0.98	0.99
Net Receivables	0.98	0.8	0.96	0.8	0.86	0.87	0.86	0.43	0.16	-0.9	0.9	0.54	0.92	0.98	0.92	0.85	0.85	0.92		0.17	-0.85	0.97	0.95	0.48	0.86	0.96
Good Will	0.28	0.44	0.38	0.27	0.56	0.38	0.11	0.81	-0.1	-0.35	0.54	0.41	0.4	0.2	-0.14	0.42	0.32	0.4	0.17		-0.34	0.04	0.04	0.72	0.32	0.36
Common Stock Total Equity	-0.93	-0.98	-0.87	-0.96	-0.72	-0.94	-0.8	-0.69	-0.46	0.81	-0.83	-0.63	-0.93	-0.9	-0.68	-0.96	-1.0	-0.93	-0.85	-0.34		-0.76	-0.9	-0.72	-0.96	-0.93
Common Stock Shares Outstanding	0.93	0.69	0.91	0.67	0.83	0.82	0.91	0.32	-0.01	-0.91	0.85	0.58	0.88	0.92	0.96	0.8	0.76	0.88	0.97	0.04	-0.76		0.9	0.34	0.82	0.9
Non Current Liabilities Total	0.95	0.86	0.88	0.9	0.69	0.85	0.8	0.39	0.41	-0.79	0.78	0.46	0.87	0.98	0.87	0.84	0.91	0.87	0.95	0.04	-0.9	0.9		0.49	0.86	0.92
Capital Lease Obligations	0.61	0.83	0.55	0.67	0.59	0.69	0.41	0.95	0.34	-0.49	0.66	0.69	0.67	0.56	0.21	0.7	0.71	0.67	0.48	0.72	-0.72	0.34	0.49		0.66	0.68
Inventory	0.94	0.94	0.89	0.86	0.8	0.99	0.91	0.71	0.27	-0.9	0.88	0.77	0.98	0.87	0.77	0.96	0.96	0.98	0.86	0.32	-0.96	0.82	0.86	0.66		0.95
Other Current Assets	0.99	0.92	0.97	0.86	0.89	0.96	0.87	0.66	0.21	-0.92	0.96	0.69	0.99	0.96	0.83	0.94	0.93	0.99	0.96	0.36	-0.93	0.9	0.92	0.68	0.95

Click cells to compare fundamentals

Maravai Lifesciences Account Relationship Matchups

Maravai Lifesciences balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	577.8M	1.3B	1.9B	2.3B	1.5B	1.5B
Short Long Term Debt Total	390.2M	590.8M	534.3M	585.3M	611.0M	559.4M
Other Current Liab	18.7M	40.8M	64.3M	88.3M	59.5M	55.1M
Total Current Liabilities	29.6M	130.8M	93.8M	110.1M	87.5M	89.4M
Total Stockholder Equity	141.4M	88.5M	315.5M	545.2M	416.8M	302.8M
Other Liab	15.9M	400.4M	713.6M	693.4M	797.4M	405.2M
Net Tangible Assets	(280.7M)	(313.4M)	315.5M	44.9M	51.6M	54.2M
Property Plant And Equipment Net	94.3M	101.3M	46.3M	116.6M	222.6M	114.4M
Current Deferred Revenue	841K	78.1M	10.2M	3.1M	3.4M	3.2M
Net Debt	365.5M	354.6M	(17.0M)	(46.9M)	36.0M	34.2M
Retained Earnings	(42.4M)	854K	184.6M	404.8M	285.7M	145.8M
Accounts Payable	7.5M	3.0M	8.2M	6.0M	10.7M	7.1M
Cash	24.7M	236.2M	551.3M	632.1M	575.0M	374.2M
Non Current Assets Total	517.2M	939.1M	1.2B	1.4B	787.5M	979.4M
Non Currrent Assets Other	805K	4.2M	52.9M	40.3M	9.3M	8.9M
Other Assets	805K	435.9M	812.5M	806.1M	927.0M	973.4M
Long Term Debt	334.8M	528.6M	524.6M	522.0M	518.7M	506.8M
Cash And Short Term Investments	24.7M	236.2M	551.3M	632.1M	575.0M	374.2M
Net Receivables	18.0M	51.0M	117.5M	146.8M	55.7M	74.3M
Liabilities And Stockholders Equity	577.8M	1.3B	1.9B	2.3B	1.5B	1.5B
Non Current Liabilities Total	403.6M	985.2M	1.3B	1.3B	610.1M	898.5M
Capital Lease Obligations	52.9M	56.2M	3.7M	57.8M	86.8M	47.5M
Inventory	14.2M	33.3M	51.6M	43.2M	51.4M	38.1M
Other Current Assets	3.6M	11.1M	19.7M	25.8M	17.8M	14.6M
Other Stockholder Equity	8.0M	85.1M	128.4M	137.9M	128.5M	90.2M
Total Liab	433.2M	1.1B	1.4B	1.4B	697.6M	987.9M
Net Invested Capital	478.7M	623.1M	846.1M	1.1B	940.9M	814.7M
Property Plant And Equipment Gross	94.3M	101.3M	46.3M	136.1M	254.9M	267.6M
Total Current Assets	60.6M	331.6M	740.0M	847.9M	699.9M	501.2M
Capital Stock	183.9M	2.6M	2.6M	2.6M	2.5M	2.4M
Non Current Liabilities Other	1.2M	2.2M	754.5M	17.4M	2.4M	2.3M
Net Working Capital	31.0M	200.8M	646.3M	737.8M	612.4M	411.8M
Intangible Assets	197.9M	177.7M	117.6M	216.7M	221.0M	210.6M
Common Stock	183.9M	2.6M	2.6M	2.6M	2.5M	2.4M
Property Plant Equipment	94.3M	101.3M	46.3M	116.6M	134.1M	88.2M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Maravai Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Maravai Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maravai Lifesciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maravai Lifesciences Holdings Stock:

How To Invest In Maravai

Details

Is Maravai Stock a good investment?

Details

What is Maravai Lifesciences' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.33)

Earnings Share

(1.67)

Revenue Per Share

2.044

Quarterly Revenue Growth

(0.03)

Return On Assets

(0.02)

The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Maravai Historical Balance Sheet

Maravai Lifesciences Inventory

38.12 Million

About Maravai Balance Sheet Analysis

Maravai Lifesciences Balance Sheet Chart

Total Assets

Total Current Liabilities

Retained Earnings

Maravai Lifesciences balance sheet Correlations

Maravai Lifesciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Maravai Lifesciences balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Other Current Assets	+ 0.99	Total Assets
Cash	+ 0.99	Other Liab
Cash And Short Term Investments	+ 0.99	Other Liab
Inventory	+ 0.99	Other Liab
Other Current Assets	+ 0.99	Cash

Common Stock Total Equity	- 1.0	Long Term Debt
Common Stock Total Equity	- 0.98	Short Long Term Debt Total
Inventory	- 0.96	Common Stock Total Equity
Common Stock Total Equity	- 0.96	Other Assets
Common Stock Total Equity	- 0.96	Total Current Liabilities
Net Debt	- 0.95	Net Tangible Assets